{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:34:07Z","timestamp":1792089247994,"version":"4.4.0"},"reference-count":189,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50006\/2025"],"award-info":[{"award-number":["UIDB\/50006\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xphs.2026.104442","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:36:00Z","timestamp":1785252960000},"page":"104442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic advances in nanomedicine, nucleic acid therapies, and AI-driven research on cervical cancer"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4177-7533","authenticated-orcid":false,"given":"Manoj","family":"Dalabehera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Poonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudra Narayan","family":"Subudhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya E.","family":"Choonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Figueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutan","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0786-6280","authenticated-orcid":false,"given":"Filipa","family":"Mascarenhas-Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0001","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.xphs.2026.104442_bib0002","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol Biol Rep"},{"issue":"12","key":"10.1016\/j.xphs.2026.104442_bib0003","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12032-023-02195-3","article-title":"Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment","volume":"40","author":"Yadav","year":"2023","journal-title":"Med Oncol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104442_bib0004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat Rev Mater"},{"issue":"24","key":"10.1016\/j.xphs.2026.104442_bib0005","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.3390\/cancers16244234","article-title":"Metal oxide nanoparticles as efficient nanocarriers for targeted cancer therapy: addressing chemotherapy-induced disabilities","volume":"16","author":"Yassin","year":"2024","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13337-023-00824-z","article-title":"HPV pathogenesis, various types of vaccines, safety concern, prophylactic and therapeutic applications to control cervical cancer, and future perspective","volume":"34","author":"Ashique","year":"2023","journal-title":"VirusDis"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/cancers15010263","article-title":"Towards novel gene and cell therapy approaches for cervical cancer","volume":"15","author":"Polten","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.xphs.2026.104442_bib0008","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12032-023-02195-3","article-title":"Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment","volume":"40","author":"Yadav","year":"2023","journal-title":"Med Oncol"},{"key":"10.1016\/j.xphs.2026.104442_bib0009","series-title":"Nanomedicine","first-page":"505","article-title":"Theranostics: Integrated diagnostics and therapy using nanomedicine","author":"Singh","year":"2024"},{"issue":"26","key":"10.1016\/j.xphs.2026.104442_bib0010","doi-asserted-by":"crossref","first-page":"16516","DOI":"10.1021\/acsnano.3c12537","article-title":"Theragnostic gadolinium-based nanoparticles safely augment X-ray radiation effects in patients with cervical cancer","volume":"18","author":"Chargari","year":"2024","journal-title":"ACS Nano,"},{"issue":"6","key":"10.1016\/j.xphs.2026.104442_bib0011","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.15354\/si.23.re833","article-title":"A perspective review of cancer therapy (Part I): immunotherapy, gene therapy, and nanotechnology","volume":"43","author":"Pajuelo","year":"2023","journal-title":"Sci Insights"},{"issue":"9","key":"10.1016\/j.xphs.2026.104442_bib0012","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41417-021-00299-4","article-title":"Nanomedicine-based cancer immunotherapy: recent trends and future perspectives","volume":"28","author":"Lakshmanan","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.xphs.2026.104442_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251336415","article-title":"Advances and challenges in cervical cancer: from molecular mechanisms and global epidemiology to innovative therapies and prevention strategies","volume":"32","author":"Hakim","year":"2025","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0014","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/biomedicines12010183","article-title":"Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review","volume":"12","author":"Eslami","year":"2024","journal-title":"Biomedicines"},{"issue":"15","key":"10.1016\/j.xphs.2026.104442_bib0015","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3390\/cancers15153837","article-title":"Precision medicine: disease subtyping and tailored treatment","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104442_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106363","article-title":"Monitoring HPV vaccine impact on cervical disease: status and future directions for the era of cervical cancer elimination","volume":"144","author":"Oliveira","year":"2021","journal-title":"Prev Med"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0017","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1039\/D0TB02168G","article-title":"Recent advances in co-delivery nanosystems for synergistic action in cancer treatment","volume":"9","author":"Carvalho","year":"2021","journal-title":"J Mater Chem B"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298815","article-title":"Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6\/E7 combined with cisplatin in a xenograft model of cervical cancer","volume":"19","author":"Kang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2026.104442_bib0019","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/IJN.S115136","article-title":"Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer","volume":"12","author":"Liu","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2026.104442_bib0020","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2147\/DDDT.S235098","article-title":"Combination treatment of cervical cancer using folate-decorated, pH-sensitive, carboplatin and paclitaxel co-loaded lipid-polymer hybrid nanoparticles","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"8","key":"10.1016\/j.xphs.2026.104442_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308599","article-title":"Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells","volume":"19","author":"Golalipour","year":"2024","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.xphs.2026.104442_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308599","article-title":"Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells","volume":"19","author":"Golalipour","year":"2024","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.xphs.2026.104442_bib0023","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.3390\/v14122824","article-title":"Advanced nanomedicine for high-risk HPV-driven head and neck cancer","volume":"14","author":"Xu","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0024","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/btm2.10022","article-title":"Targeting HPV-infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine","volume":"1","author":"Levine","year":"2016","journal-title":"Bioeng Transl Med"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12668-022-00961-7","article-title":"Preparation, characterization, and anticancer efficacy of chitosan, chitosan encapsulated piperine and probiotics (Lactobacillus plantarum (MTCC-1407), and Lactobacillus rhamnosus (MTCC-1423) nanoparticles","volume":"12","author":"Gunasangkaran","year":"2022","journal-title":"BioNanoScience"},{"key":"10.1016\/j.xphs.2026.104442_bib0026","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.4c17079","article-title":"Unveiling the cytotoxic potential of quercetin-loaded magnetic bacterial bots against cervical cancer","author":"Roy","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.xphs.2026.104442_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104073","article-title":"Metal-based approaches to fight cervical cancer","author":"Pereira","year":"2024","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.xphs.2026.104442_bib0028","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/20415990.2024.2442301","article-title":"Iron oxide nanoparticles: a versatile nanoplatform for the treatment and diagnosis of ovarian cancer","volume":"16","author":"Poonia","year":"2025","journal-title":"Therapeutic Deliv"},{"issue":"8","key":"10.1016\/j.xphs.2026.104442_bib0029","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s43630-021-00082-2","article-title":"Controlled killing of human cervical cancer cells by combined action of blue light and C-doped TiO2 nanoparticles","volume":"20","author":"Matijevi\u0107","year":"2021","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0030","article-title":"Brucine entrapped titanium oxide nanoparticle for anticancer treatment: an in vitro study","volume":"2024","author":"Almuqbil","year":"2024","journal-title":"Adv Pharmacol Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12645-022-00134-x","article-title":"Zinc oxide nanoparticle regulates the ferroptosis, proliferation, invasion and stemness of cervical cancer by miR-506-3p\/CD164 signaling","volume":"13","author":"Lei","year":"2022","journal-title":"Cancer Nanotechnol"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0032","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jsps.2017.12.010","article-title":"Chitosan-based zinc oxide nanoparticle for enhanced anticancer effect in cervical cancer: a physicochemical and biological perspective","volume":"26","author":"Wu","year":"2018","journal-title":"Saudi Pharm J"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0033","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jpp\/rgaa043","article-title":"Zinc oxide nanoparticles synthesized from Aspergillus terreus induces oxidative stress-mediated apoptosis through modulating apoptotic proteins in human cervical cancer HeLa cells","volume":"73","author":"Chen","year":"2021","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2026.104442_bib0034","doi-asserted-by":"crossref","unstructured":"Maheswaran, H., Djearamane, S., Dhanapal, A.C.T.A. and Shing, W.L. (2023). Cytotoxic study of zinc oxide nanoparticles on cervical cancer cell line.","DOI":"10.18006\/2023.11(5).815.821"},{"key":"10.1016\/j.xphs.2026.104442_bib0035","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2147\/IJN.S361483","article-title":"Systematic identification of genomic markers for guiding iron oxide nanoparticles in cervical cancer based on translational bioinformatics","volume":"17","author":"Zhou","year":"2022","journal-title":"Int J Nanomed"},{"issue":"12","key":"10.1016\/j.xphs.2026.104442_bib0036","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1039\/D0NA00686F","article-title":"Development of label-free gold nanoparticle based rapid colorimetric assay for clinical\/point-of-care screening of cervical cancer","volume":"2","author":"Appidi","year":"2020","journal-title":"Nanoscale Adv"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0037","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/s41598-024-52217-x","article-title":"Green synthesis of zinc oxide nanoparticles using aqueous extract of shilajit and their anticancer activity against HeLa cells","volume":"14","author":"Perumal","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xphs.2026.104442_bib0038","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1007\/s12011-021-02898-6","article-title":"Synthesis and characterization of zinc oxide nanoparticles of solanum nigrum and its anticancer activity via the induction of apoptosis in cervical cancer","volume":"200","author":"Thomas","year":"2022","journal-title":"Biol Trace Elem Res"},{"issue":"73","key":"10.1016\/j.xphs.2026.104442_bib0039","doi-asserted-by":"crossref","first-page":"46271","DOI":"10.1039\/C7RA06615E","article-title":"Magneto-chemotherapy for cervical cancer treatment with camptothecin loaded Fe3O4 functionalized \u03b2-cyclodextrin nanovehicle","volume":"7","author":"Rajan","year":"2017","journal-title":"RSC Adv"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/nano7050111","article-title":"Core-shell magnetic gold nanoparticles for magnetic field-enhanced radio-photothermal therapy in cervical cancer","volume":"7","author":"Hu","year":"2017","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.xphs.2026.104442_bib0041","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acsabm.1c01311","article-title":"Folic acid-adorned curcumin-loaded iron oxide nanoparticles for cervical cancer","volume":"5","author":"Ramezani Farani","year":"2022","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0042","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/21691401.2021.1890101","article-title":"Inhibiting the PI3K\/AKT\/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells","volume":"49","author":"Chen","year":"2021","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"10","key":"10.1016\/j.xphs.2026.104442_bib0043","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3390\/polym15102393","article-title":"Copolymer-green-synthesized copper oxide nanoparticles enhance folate-targeting in cervical cancer cells in vitro","volume":"15","author":"Jagaran","year":"2023","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0044","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/jrptps.JRPTPS_109_20","article-title":"Tin (IV) oxide (SnO2) nanoparticles inhibit the viability of cervical cancer HeLa cells through induction of apoptosis","volume":"10","author":"Bazsefidpar","year":"2021","journal-title":"J Rep Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6121328","article-title":"Silver nanoparticles potentiates cytotoxicity and apoptotic potential of camptothecin in human cervical cancer cells","volume":"2018","author":"Yuan","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"10.1016\/j.xphs.2026.104442_bib0046","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.xphs.2026.104442_bib0047","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1007\/s12668-024-01496-9","article-title":"Polymeric nanostructures revolutionizing cervical cancer: diagnostics, therapeutics, and theranostics","volume":"14","author":"Dey","year":"2024","journal-title":"BioNanoScience"},{"issue":"9","key":"10.1016\/j.xphs.2026.104442_bib0048","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/gels9090713","article-title":"Imiquimod-loaded chitosan-decorated di-block and tri-block polymeric nanoparticles loaded In situ gel for the management of cervical cancer","volume":"9","author":"Almomen","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.xphs.2026.104442_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112584","article-title":"A cationic amino acid polymer nanocarrier synthesized in supercritical CO2 for co-delivery of drug and gene to cervical cancer cells","volume":"216","author":"Kavya","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40204-022-00179-6","article-title":"Artificial neural network for optimizing the formulation of curcumin-loaded liposomes from statistically designed experiments","volume":"11","author":"Cardoso-Daodu","year":"2022","journal-title":"Prog Biomater"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0051","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/cancers17050878","article-title":"Advancing cancer therapy with quantum dots and other nanostructures: a review of drug delivery innovations, applications, and challenges","volume":"17","author":"Pareek","year":"2025","journal-title":"Cancers"},{"issue":"48","key":"10.1016\/j.xphs.2026.104442_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204562","article-title":"Therapeutic potential of chlorophyll functionalized carbon quantum dots against cervical cancer","volume":"7","author":"Alam","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.xphs.2026.104442_bib0053","article-title":"Magnetic nanoparticles and quantum dots coupled immuno nano fluorescence assay for visual detection of HPV16-induced cervical cancer cells from cytology\/biopsy samples","volume":"46","author":"Raman","year":"2024","journal-title":"Sens Bio-Sens Res"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0054","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s42003-021-01713-1","article-title":"Biocompatible nucleus-targeted graphene quantum dots for selective killing of cancer cells via DNA damage","volume":"4","author":"Qi","year":"2021","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.xphs.2026.104442_bib0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1039\/c2ib20269g","article-title":"Quantum dots (QDs) restrain human cervical carcinoma HeLa cell proliferation through inhibition of the ROCK-c-Myc signaling","volume":"5","author":"Chen","year":"2013","journal-title":"Integr Biol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0056","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-021-00631-2","article-title":"Recent progress in targeted delivery vectors based on biomimetic nanoparticles","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.xphs.2026.104442_bib0057","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.7150\/thno.41228","article-title":"Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0058","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1039\/D0TB02168G","article-title":"Recent advances in co-delivery nanosystems for synergistic action in cancer treatment","volume":"9","author":"Carvalho","year":"2021","journal-title":"J Mater Chem B"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0059","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13287-024-04006-6","article-title":"Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0060","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13287-024-04006-6","article-title":"Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"28","key":"10.1016\/j.xphs.2026.104442_bib0061","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17933","article-title":"MicroRNA-145 down-regulates mucin 5AC to alleviate airway remodeling and targets EGFR to inhibit cytokine expression","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.xphs.2026.104442_bib0062","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.7150\/thno.39434","article-title":"Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs","volume":"10","author":"Qiao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.xphs.2026.104442_bib0063","article-title":"Non-coding RNAs-based therapy and angiogenesis: a new era for the management of gliomas","author":"Beylerli","year":"2025","journal-title":"Curr Gene Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0064","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13287-024-04006-6","article-title":"Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.xphs.2026.104442_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149403","article-title":"CAFs-derived exosomes promote the development of cervical cancer by regulating miR-18a-5p-TMEM170B signaling axis","volume":"694","author":"Kang","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xphs.2026.104442_bib0066","series-title":"Nanomaterials for medical diagnosis and therapy","author":"Kumar","year":"2007"},{"key":"10.1016\/j.xphs.2026.104442_bib0067","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1021\/jm060515m","article-title":"Multivalent effects of RGD peptides obtained by nanoparticle display","volume":"49","author":"Montet","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.xphs.2026.104442_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213077","article-title":"Advances in aptamer-based drug delivery vehicles for cancer therapy","volume":"140","author":"Ghasemii","year":"2022","journal-title":"Biomater Adv"},{"key":"10.1016\/j.xphs.2026.104442_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111270","article-title":"Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer","volume":"196","author":"Dana","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2026.104442_bib0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1175535","article-title":"CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach","volume":"14","author":"Kousar","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xphs.2026.104442_bib0071","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45537-x","article-title":"Development and pharmaceutical investigation of novel cervical cancer-targeting and redox-responsive melittin conjugates","volume":"13","author":"Sahsuvar","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104442_bib0072","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.msec.2018.09.044","article-title":"Synthesis of multifunctional Fe3O4@PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer","volume":"94","author":"You","year":"2019","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.xphs.2026.104442_bib0073","first-page":"1","article-title":"Carbon dots-embedded epitope imprinted polymer for targeted fluorescence imaging of cervical cancer via recognition of epidermal growth factor receptor","volume":"187","author":"Zhang","year":"2020","journal-title":"Microchim Acta"},{"key":"10.1016\/j.xphs.2026.104442_bib0074","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13568-020-00990-z","article-title":"CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells","volume":"10","author":"Wang","year":"2020","journal-title":"AMB Express"},{"key":"10.1016\/j.xphs.2026.104442_bib0075","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.2147\/IJN.S298252","article-title":"TMTP1-Modified, tumor microenvironment responsive nanoparticles co-deliver cisplatin and paclitaxel prodrugs for effective cervical cancer therapy","volume":"16","author":"Jiang","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2026.104442_bib0076","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3390\/cancers12051301","article-title":"Targeted gene delivery therapies for cervical cancer","volume":"12","author":"Ayen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104442_bib0077","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12094-019-02131-w","article-title":"Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro","volume":"22","author":"Yu","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.xphs.2026.104442_bib0078","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40001-023-01014-9","article-title":"siRNA-E6 sensitizes HPV-16-related cervical cancer through oxaliplatin: an in vitro study on anti-cancer combination therapy","volume":"28","author":"Shiri Aghbash","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.xphs.2026.104442_bib0079","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2147\/IJN.S258316","article-title":"A novel targeted therapy system for cervical cancer: co-delivery system of antisense LncRNA of MDC1 and oxaliplatin magnetic thermosensitive cationic liposome drug carrier","volume":"16","author":"Ye","year":"2021","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2026.104442_bib0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41417-021-00366-w","article-title":"The application of CRISPR\/Cas9 system in cervical carcinogenesis","volume":"29","author":"Gao","year":"2022","journal-title":"Cancer Gene Ther,"},{"key":"10.1016\/j.xphs.2026.104442_bib0081","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41417-019-0131-9","article-title":"Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout","volume":"27","author":"Zhen","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.xphs.2026.104442_bib0082","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1007\/s43032-021-00479-5","article-title":"MicroRNA-143 sensitizes cervical cancer cells to cisplatin: a promising anticancer combination therapy","volume":"28","author":"Esfandyari","year":"2021","journal-title":"Reprod Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0083","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.3390\/cancers15225453","article-title":"Enhancing cervical cancer prevention in South African women: primary HPV mRNA screening with different genotype combinations","volume":"15","author":"S\u00f8rbye","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104442_bib0084","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1038\/s41598-020-62448-3","article-title":"Combination therapy using human papillomavirus L1\/E6\/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer","volume":"10","author":"Karimi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104442_bib0085","article-title":"Promising nanocarriers for PEDF gene targeting delivery to cervical cancer cells mediated by the over-expressing FR\u03b1","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xphs.2026.104442_bib0086","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1039\/C6TB02990F","article-title":"Poly-\u03b3-glutamic acid-based GGT-targeting and surface camouflage strategy for improving cervical cancer gene therapy","volume":"5","author":"Tan","year":"2017","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.xphs.2026.104442_bib0087","first-page":"57","article-title":"Combining imaging-and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity","author":"Fjeldbo","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xphs.2026.104442_bib0088","doi-asserted-by":"crossref","DOI":"10.1177\/20406223241233206","article-title":"Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules","volume":"15","author":"Shanazarov","year":"2024","journal-title":"Ther Adv Chronic Dis"},{"issue":"34","key":"10.1016\/j.xphs.2026.104442_bib0089","doi-asserted-by":"crossref","first-page":"20850","DOI":"10.1039\/D1RA02875H","article-title":"Polymer encapsulated clinical ICG nanoparticles for enhanced photothermal therapy and NIR fluorescence imaging in cervical cancer","volume":"11","author":"Chen","year":"2021","journal-title":"RSC Adv"},{"issue":"6","key":"10.1016\/j.xphs.2026.104442_bib0090","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1039\/D2RA03055A","article-title":"Liposomes loaded with dual clinical photosensitizers for enhanced photodynamic therapy of cervical cancer","volume":"13","author":"Alimu","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104442_bib0091","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1301440","article-title":"Effects of 5-aminolevulinic acid photodynamic therapy for cervical low-grade squamous intraepithelial lesions with HR-HPV infections","volume":"10","author":"Li","year":"2024","journal-title":"Front Med"},{"issue":"3","key":"10.1016\/j.xphs.2026.104442_bib0092","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/ijms22031172","article-title":"Photodynamic and cold atmospheric plasma combination therapy using polymeric nanoparticles for the synergistic treatment of cervical cancer","volume":"22","author":"Ha","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.xphs.2026.104442_bib0093","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411565","article-title":"Anti-cancer effect of chlorophyllin-assisted photodynamic therapy to induce apoptosis through oxidative stress on human cervical cancer","volume":"24","author":"Heo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0094","first-page":"1","article-title":"Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines","author":"Javani Jouni","year":"2022","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0095","first-page":"1","article-title":"Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines","author":"Javani Jouni","year":"2022","journal-title":"Lasers Med Sci"},{"issue":"43","key":"10.1016\/j.xphs.2026.104442_bib0096","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.18632\/oncotarget.27029","article-title":"Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells","volume":"10","author":"Chizenga","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.xphs.2026.104442_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102385","article-title":"Integration of immunotherapy into treatment of cervical cancer: recent data and ongoing trials","volume":"106","author":"Monk","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.xphs.2026.104442_bib0098","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001680","article-title":"Engineered multifunctional nano-and biological materials for cancer immunotherapy","volume":"10","author":"Brouillard","year":"2021","journal-title":"Adv Healthc Mater"},{"issue":"3","key":"10.1016\/j.xphs.2026.104442_bib0099","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/life14030344","article-title":"Immunotherapy in cervical and endometrial cancer: current landscape and future directions","volume":"14","author":"Stefanoudakis","year":"2024","journal-title":"Life"},{"issue":"18","key":"10.1016\/j.xphs.2026.104442_bib0100","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.3390\/cancers14184458","article-title":"Immune landscape and immunotherapy options in cervical carcinoma","volume":"14","author":"Kousar","year":"2022","journal-title":"Cancers"},{"issue":"20","key":"10.1016\/j.xphs.2026.104442_bib0101","doi-asserted-by":"crossref","first-page":"12830","DOI":"10.1021\/acsnano.4c00017","article-title":"Gas-amplified metalloimmunotherapy with dual activation of pyroptosis and the STING pathway for remodeling the immunosuppressive cervical cancer microenvironment","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.xphs.2026.104442_bib0102","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/1568009622666220609115109","article-title":"Localized nano-mediated interleukin-12 gene therapy: promising candidate for cancer immunotherapeutics","volume":"22","author":"Venkatas","year":"2022","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"10.1016\/j.xphs.2026.104442_bib0103","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.xphs.2026.104442_bib0104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized interleukin-12 for cancer immunotherapy","volume":"11","author":"Nguyen","year":"2020","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.xphs.2026.104442_bib0105","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2217\/nnm-2023-0076","article-title":"Curcumin-reduced gold nanoparticles facilitate IL-12 delivery to a cervical cancer in vitro cell model","volume":"18","author":"Venkatas","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.xphs.2026.104442_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154958","article-title":"Immunostimulatory effect of chitosan conjugated green copper oxide nanoparticles in tumor immunotherapy","volume":"127","author":"Dey","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0107","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12985-024-02397-9","article-title":"The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)","volume":"21","author":"Movahed","year":"2024","journal-title":"Virol J"},{"key":"10.1016\/j.xphs.2026.104442_bib0108","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1386167","article-title":"Cervical cancer prevention by vaccination","volume":"14","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.xphs.2026.104442_bib0109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/ITT.S273327","article-title":"Therapeutic vaccines for HPV-associated malignancies","volume":"9","author":"Smalley Rumfield","year":"2020","journal-title":"ImmunoTargets Ther"},{"issue":"6","key":"10.1016\/j.xphs.2026.104442_bib0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0112","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1039\/D2BM01715F","article-title":"A sugar modified amphiphilic cationic nano-adjuvant ceased tumor immune suppression and rejuvenated peptide vaccine induced antitumor immunity in cervical cancer","volume":"11","author":"Mohapatra","year":"2023","journal-title":"Biomater Sci"},{"issue":"4","key":"10.1016\/j.xphs.2026.104442_bib0113","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29571","article-title":"Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model","volume":"96","author":"Arvizu-Hernandez","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.xphs.2026.104442_bib0114","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2147\/DDDT.S235098","article-title":"Combination treatment of cervical cancer using folate-decorated, pH-sensitive, carboplatin and paclitaxel co-loaded lipid-polymer hybrid nanoparticles","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0115","first-page":"608","article-title":"Combination therapies for HPV-associated malignancies","volume":"12","author":"Rumfiled","year":"2020","journal-title":"J Clin Cell Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0116","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10799893.2018.1426610","article-title":"Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K\/AKT\/mTOR pathways","volume":"38","author":"Dong","year":"2018","journal-title":"J Recept Signal Transduct"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0117","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41598-021-04618-5","article-title":"Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer","volume":"12","author":"Gordhandas","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2026.104442_bib0118","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.sajb.2019.10.003","article-title":"Moringa oleifera and vesicular stomatitis virus: a combination approach for the treatment of cervical cancers","volume":"129","author":"Brown","year":"2020","journal-title":"S Afr J Bot"},{"key":"10.1016\/j.xphs.2026.104442_bib0119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2016.01.012","article-title":"Synergistic anticancer activity of dietary tea polyphenols and bleomycin hydrochloride in human cervical cancer cell: caspase-dependent and independent apoptotic pathways","volume":"247","author":"Alshatwi","year":"2016","journal-title":"Chem-Biol Interact"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0120","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/cancers15020548","article-title":"Synergistic combination of luteolin and asiatic acid on cervical cancer in vitro and in vivo","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104442_bib0121","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2147\/DDDT.S235098","article-title":"Combination treatment of cervical cancer using folate-decorated, pH-sensitive, carboplatin and paclitaxel co-loaded lipid-polymer hybrid nanoparticles","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0122","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10717544.2021.1886378","article-title":"Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells","volume":"28","author":"Wang","year":"2021","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0123","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1936391","article-title":"Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer","volume":"10","author":"Kol","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.xphs.2026.104442_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110177","article-title":"Combination treatment with cyclosporin A and arsenic trioxide induce synergistic cell death via non-apoptotic pathway in uterine cervical cancer cells","volume":"368","author":"Wu","year":"2022","journal-title":"Chem-Biol Interact"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0125","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1039\/D0RA07309A","article-title":"Effect of naringenin and its combination with cisplatin in cell death, proliferation and invasion of cervical cancer spheroids","volume":"11","author":"Mart\u00ednez-Rodr\u00edguez","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.xphs.2026.104442_bib0126","article-title":"Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential in vitro and in vivo","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.xphs.2026.104442_bib0127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2018.01.003","article-title":"Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells","volume":"63","author":"He","year":"2018","journal-title":"DNA Repair"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phymed.2012.10.009","article-title":"Combination of phenylpropanoids with 5-fluorouracil as anti-cancer agents against human cervical cancer (HeLa) cell line","volume":"20","author":"Hemaiswarya","year":"2013","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.xphs.2026.104442_bib0129","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.3390\/ijms20143383","article-title":"Inhibition of phosphatidylinositol 3-kinase (PI3K) signaling synergistically potentiates antitumor efficacy of paclitaxel and overcomes paclitaxel-mediated resistance in cervical cancer","volume":"20","author":"Liu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8345235","article-title":"TILs and Anti-PD1 therapy: an alternative combination therapy for PDL1 negative metastatic cervical cancer","volume":"2020","author":"Yin","year":"2020","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.xphs.2026.104442_bib0131","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3390\/ijms24031988","article-title":"Treatment of HPV-related uterine cervical cancer with a third-generation oncolytic herpes simplex virus in combination with an immune checkpoint inhibitor","volume":"24","author":"Kagabu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2026.104442_bib0132","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104892","article-title":"Therapeutic effect of cold atmospheric plasma and its combination with radiation as a novel approach on inhibiting cervical cancer cell growth (HeLa cells)","volume":"111","author":"Kenari","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.xphs.2026.104442_bib0133","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.biopha.2016.12.042","article-title":"Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer","volume":"86","author":"Li","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.xphs.2026.104442_bib0134","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1007\/s13277-015-4526-4","article-title":"Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8\/caspase-3 and the mitochondria-dependent apoptotic pathway","volume":"37","author":"Lin","year":"2016","journal-title":"Tumour Biol"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0135","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.3892\/ol.2017.5901","article-title":"Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: a clinical trial","volume":"13","author":"Xiao","year":"2017","journal-title":"Oncol Lett"},{"issue":"5","key":"10.1016\/j.xphs.2026.104442_bib0136","first-page":"7397","article-title":"Synergistic effects of cisplatin-caffeic acid induces apoptosis in human cervical cancer cells via the mitochondrial pathways","volume":"15","author":"Koraneekit","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.xphs.2026.104442_bib0137","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejphar.2019.01.045","article-title":"Metformin combined with nelfinavir induces SIRT3\/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice","volume":"848","author":"Xia","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0138","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12906-025-04817-x","article-title":"Cytotoxic and immunomodulatory properties of Tinospora cordifolia, Boerhaavia diffusa, Berberis aristata, and Ocimum basilicum extracts against HPV-positive cervical cancer cell line","volume":"25","author":"Vaghasia","year":"2025","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.xphs.2026.104442_bib0139","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1476152","article-title":"Combination of Vitex pseudo-negundo methanolic-extract with cisplatin can induce antioxidant activity and apoptosis in HeLa and Caski cells","volume":"15","author":"Shiri Aghbash","year":"2024","journal-title":"Front Pharmacol"},{"issue":"35","key":"10.1016\/j.xphs.2026.104442_bib0140","doi-asserted-by":"crossref","first-page":"31826","DOI":"10.1021\/acsomega.3c03337","article-title":"Carvacrol-fabricated chitosan nanoparticle synergistic potential with topoisomerase inhibitors on breast and cervical cancer cells","volume":"8","author":"Akhlaq","year":"2023","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.xphs.2026.104442_bib0141","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/cancers15020548","article-title":"Synergistic combination of luteolin and asiatic acid on cervical cancer in vitro and in vivo","volume":"15","author":"Chen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.xphs.2026.104442_bib0142","first-page":"80","article-title":"Performance of artificial intelligence for diagnosing cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis","author":"Liu","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.xphs.2026.104442_bib0143","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.788376","article-title":"Machine learning assisted cervical cancer detection","volume":"9","author":"Mehmood","year":"2021","journal-title":"Front Public Health"},{"issue":"12","key":"10.1016\/j.xphs.2026.104442_bib0144","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.3390\/jcm12124024","article-title":"Pivotal clinical study to evaluate the efficacy and safety of assistive artificial intelligence-based software for cervical cancer diagnosis","volume":"12","author":"Kim","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0145","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12885-024-12532-y","article-title":"Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.xphs.2026.104442_bib0146","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1038\/s41598-022-07723-1","article-title":"Predictions of cervical cancer identification by photonic method combined with machine learning","volume":"12","author":"Kruczkowski","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.xphs.2026.104442_bib0147","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/tomography7030031","article-title":"Combination of radiomics and machine learning with diffusion-weighted MR imaging for clinical outcome prognostication in cervical cancer","volume":"7","author":"Jajodia","year":"2021","journal-title":"Tomography"},{"key":"10.1016\/j.xphs.2026.104442_bib0148","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00309959."},{"key":"10.1016\/j.xphs.2026.104442_bib0149","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT02479178."},{"key":"10.1016\/j.xphs.2026.104442_bib0150","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT06048367."},{"key":"10.1016\/j.xphs.2026.104442_bib0151","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT02646319."},{"key":"10.1016\/j.xphs.2026.104442_bib0152","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT02020707."},{"key":"10.1016\/j.xphs.2026.104442_bib0153","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00054444."},{"key":"10.1016\/j.xphs.2026.104442_bib0154","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00030472."},{"key":"10.1016\/j.xphs.2026.104442_bib0155","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00189410."},{"key":"10.1016\/j.xphs.2026.104442_bib0156","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT04580771."},{"key":"10.1016\/j.xphs.2026.104442_bib0157","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT06023862."},{"key":"10.1016\/j.xphs.2026.104442_bib0158","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT06878222."},{"key":"10.1016\/j.xphs.2026.104442_bib0159","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT02529930."},{"key":"10.1016\/j.xphs.2026.104442_bib0160","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT04256213."},{"key":"10.1016\/j.xphs.2026.104442_bib0161","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT02849340."},{"key":"10.1016\/j.xphs.2026.104442_bib0162","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT04188860."},{"key":"10.1016\/j.xphs.2026.104442_bib0163","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00075569."},{"key":"10.1016\/j.xphs.2026.104442_bib0164","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT02866006."},{"key":"10.1016\/j.xphs.2026.104442_bib0165","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT05531981."},{"key":"10.1016\/j.xphs.2026.104442_bib0166","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00988559."},{"key":"10.1016\/j.xphs.2026.104442_bib0167","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT00512551."},{"key":"10.1016\/j.xphs.2026.104442_bib0168","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN429076413&_cid=P12-MCWX4V-05794-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0169","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2011111392&_cid=P12-MCWX5X-06692-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0170","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=EP133851895&_cid=P12-MCWX84-08842-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0171","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=MX130557788&_cid=P12-MCWX9H-10148-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0172","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN431387187&_cid=P12-MCWXCJ-13053-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0173","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=KR4167123&_cid=P12-MCWXDM-14168-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0174","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN212117024&_cid=P12-MCWXF0-15522-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0175","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN220982971&_cid=P12-MCWXFS-16327-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0176","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN288653740&_cid=P12-MCWXGL-17052-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0177","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN235515045&_cid=P12-MCWXY2-33882-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0178","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN333435035&_cid=P12-MCWXYN-34535-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0179","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN297075355&_cid=P12-MCWXZB-35257-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0180","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=US329766026&_cid=P12-MCWY02-35960-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0181","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=IN393400124&_cid=P12-MCWY12-37039-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0182","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=US375123154&_cid=P12-MCWY1M-37629-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0183","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN242654821&_cid=P12-MCWY2R-38766-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0184","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=IN306152785&_cid=P12-MCWY4D-40438-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0185","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=US413456132&_cid=P12-MCWY5H-41553-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0186","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=US402829357&_cid=P12-MCWY7C-43351-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0187","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=CN313898036&_cid=P12-MCWY80-44030-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0188","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=IN414830283&_cid=P12-MCWYAN-47067-1."},{"key":"10.1016\/j.xphs.2026.104442_bib0189","unstructured":"https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=IN414845684&_cid=P12-MCWYBH-48015-1."}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:28:48Z","timestamp":1790803728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926002911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":189,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022354926002911"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104442","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic advances in nanomedicine, nucleic acid therapies, and AI-driven research on cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104442"}}